Don't be caught off-guard: Cardiovascular Systems CSII releases its next round of earnings Wednesday. Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters guide for Wednesday's Q3 earnings announcement after the bell.
Earnings and Revenue
Wall Street expects an earnings loss of 2 cents per share and sales around $55.7 million.
In the same quarter last year, Cardiovascular Systems reported earnings of 3 cents per share on revenue of $52.1 million. Revenue would be up 6.86 percent on a year-over-year basis. Here's how the company's reported EPS has compared to analyst estimates in the past:
| Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
| EPS Estimate | -0.04 | -0.07 | -0.05 | -0.05 |
| EPS Actual | -0.01 | -0.06 | 0.02 | 0.03 |
Stock Performance
Over the last 52-week period, shares are down 24.01 percent. Given that these returns are generally negative, long-term shareholders won't be happy going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analyst estimates are adjusted lower for EPS and revenues over the past 90 days. The most common rating by analysts on Cardiovascular Systems stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Cardiovascular Systems is scheduled to hold a conference call at 4:45 p.m. ET and it can be accessed here: https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
